Inactivation of the extrinsic apoptotic pathway in ALK plus anaplastic large cell lymphoma (ALCL)

被引：0
|
作者：
Oyarzo, MP [1 ]
Medeiros, LI [1 ]
Atwell, C [1 ]
Wang, S [1 ]
Drakos, E [1 ]
Rassidakis, GZ [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2005年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1133
引用
收藏
页码：244A / 244A
页数：1
相关论文
共 50 条
  • [21] MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF ALK plus AND ALK-ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)-DERIVED EXOSOMES AND THEIR INTERACTIONS WITH TUMOR MICROENVIRONMENT
    Rassidakis, G.
    Chioureas, D.
    Tsesmetzis, N.
    Drakos, E.
    Panaretakis, T.
    HAEMATOLOGICA, 2016, 101 : 569 - 570
  • [22] Anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) of breast in a patient without a breast implant
    Sathyanarayanan, Vishwanath
    Lokesh, Kadabur Nagendrappa
    Lakshmaiah, K. C.
    Babu, Govind K.
    Lokanatha, D.
    Babu, Suresh M. C.
    Rao, Clementina Rama
    Chennagiri, Premalata
    ANNALS OF SAUDI MEDICINE, 2014, 34 (06) : 551 - 554
  • [23] RESISTANCE TO ANAPLASTIC LYMPHOMA KINASE (ALK) TYROSINE KINASE INHIBITORS (TKIs) IN PAEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
    Hare, L.
    Prokoph, N.
    Burke, A.
    Turner, S.
    LEUKEMIA RESEARCH, 2022, 121 : S14 - S16
  • [24] β-Catenin activity contributes to tumor cell survival and proliferation in NPM-ALK plus anaplastic large cell lymphoma (ALCL)
    Rassidakis, G.
    Karanikou, M.
    Drakos, E.
    Medeiros, L. J.
    Georgoulis, P.
    Vassilakopoulos, T.
    Panayiotidis, P.
    Patsouris, E.
    VIRCHOWS ARCHIV, 2011, 459 : S99 - S99
  • [25] Evidence for additional variant ALK gene fusions in anaplastic large cell lymphoma (ALCL).
    Colleoni, GWB
    Garicochea, B
    Lui, MY
    Bridge, J
    Filippa, DA
    Ladanyi, M
    Lieverman, PH
    BLOOD, 1999, 94 (10) : 301A - 301A
  • [26] Is myeloid antigen expression a marker of ALK plus anaplastic large cell lymphomas (ALCL)?
    Bovio, I. M.
    Allan, R. W.
    LABORATORY INVESTIGATION, 2008, 88 : 246A - 246A
  • [27] Unmasking the true face of Alk-positive anaplastic large cell lymphoma (ALCL)
    Eisfeld, H.
    Kircher, S.
    Rosenwald, A.
    Hochhaus, A.
    Schrenk, K. G.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 146 - 147
  • [28] Is myeloid antigen expression a marker of ALK plus anaplastic large cell lymphomas (ALCL)?
    Bovio, I. M.
    Allan, R. W.
    MODERN PATHOLOGY, 2008, 21 : 246A - 246A
  • [29] T- and B-cell response to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large cell lymphoma (ALCL).
    Ait-Tahar, K
    Hatton, CSR
    Banham, AH
    Roberton, H
    Pulford, K
    BLOOD, 2003, 102 (11) : 897A - 898A
  • [30] The outcome of ALK positive and ALK negative anaplastic large cell lymphoma (ALCL) following DA-EPOCH
    Lai, Catherine
    Pittaluga, Stefania
    Shovlin, Margaret
    Steinberg, Seth M.
    Roschewski, Mark J.
    Jaffe, Elaine S.
    Wilson, Wyndham Hopkins
    Dunleavy, Kieron
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345